Infectious Diseases Division, Internal Medicine Department, Federal University of the Triângulo Mineiro, Av. Getúlio Guaritá, 430, Bairro Nossa Senhora da Abadia, PO Box: 118, Uberaba, Minas Gerais State, CEP: 38025-350, Brazil.
Federal University of the Triângulo Mineiro, Uberaba, Minas Gerais State, Brazil.
BMC Infect Dis. 2021 Sep 29;21(1):1022. doi: 10.1186/s12879-021-06648-w.
Cardiac autonomic dysfunction in HIV+ patients on different antiretroviral therapy (ART) regimens has been described. We aimed to characterize parameters of heart rate variability (HRV) and correlate with different classes of ART in HIV+ patients in three experimental conditions: rest, cold face, and tilt tests.
Cross-sectional study with three groups of age- and gender-matched individuals: group 1, 44 HIV+ patients undergoing combination therapy, with two nucleoside reverse transcriptase inhibitors (NRTI) and one non-nucleoside reverse transcriptase inhibitor (NNRTI); group 2, 42 HIV+ patients using two NRTI and protease inhibitors (PI's); and group 3, 35 healthy volunteers with negative HIV serology (control group). Autonomic function at rest and during cold face- and tilt-tests was assessed through computerized analysis of HRV, via quantification of time- and frequency domains by linear and non-linear parameters in the three groups.
Anthropometric and clinical parameters were similar between both HIV groups, except CD4+ T lymphocytes, which were significantly lower in group 2 (p = 0.039). At baseline, time-domain linear HRV parameters, RMSSD and pNN50, and the correlation dimension, a non-linear HRV parameter (p < 0.001; p = 0.018; p = 0.019, respectively), as well as response of RMSSD to cold face test were also lower in the HIV+ group than in the control individuals (p < 0.001), while no differences among groups were detected in HRV parameters during the tilt test.
Despite ART regimens, HIV+ patients presented lower cardiac vagal modulation than controls, whereas no difference was observed among the HIV groups, suggesting that higher cardiovascular risk linked to PIs may be associated with factors other than autonomic dysfunction.
已描述了不同抗逆转录病毒疗法(ART)方案下 HIV+ 患者的心脏自主神经功能障碍。我们旨在描述 HIV+ 患者在三种实验条件下(休息、冷面和倾斜试验)的心率变异性(HRV)参数,并与不同类别的 ART 相关。
这是一项横断面研究,分为三组:年龄和性别匹配的个体,组 1,44 名接受联合治疗的 HIV+ 患者,包括两种核苷逆转录酶抑制剂(NRTI)和一种非核苷逆转录酶抑制剂(NNRTI);组 2,42 名使用两种 NRTI 和蛋白酶抑制剂(PI)的 HIV+ 患者;组 3,35 名 HIV 血清学阴性的健康志愿者(对照组)。通过计算机分析 HRV,评估自主神经功能在休息和冷面及倾斜试验期间的变化,通过线性和非线性参数在三组中量化时间和频率域。
两组 HIV 患者的人体测量学和临床参数相似,除了 CD4+T 淋巴细胞,组 2 明显较低(p=0.039)。在基线时,线性 HRV 时域参数,RMSSD 和 pNN50,以及非线性 HRV 参数的关联维数(p<0.001;p=0.018;p=0.019,分别),以及 RMSSD 对冷面试验的反应在 HIV+组也低于对照组(p<0.001),而在倾斜试验期间,HRV 参数在三组之间没有差异。
尽管有 ART 方案,HIV+患者的心脏迷走神经调节功能仍低于对照组,而在 HIV 组之间没有差异,这表明与 PI 相关的更高心血管风险可能与自主神经功能障碍以外的因素有关。